| 2008 |
Hepatocyte-specific knockout of Nrf1 causes liver damage resembling non-alcoholic steatohepatitis, and while Nrf2 is activated compensatorily, it cannot fully substitute for Nrf1. Nrf1, but not Nrf2, preferentially transactivates the metallothionein-1 and -2 (MT1/MT2) ARE, identifying MT1/MT2 as the first ARE-dependent genes that exclusively rely on Nrf1. |
Hepatocyte-specific Nrf1 conditional knockout mice; gene expression analysis; reporter gene assays with MT1 ARE; ARE binding assays |
The Journal of biological chemistry |
High |
18826952
|
| 2003 |
Loss of both Nrf1 and Nrf2 causes early embryonic lethality (E9-10) with extensive apoptosis and severe oxidative stress, including elevated ROS and impaired antioxidant gene expression; single mutants survive longer, demonstrating overlapping but non-redundant functions in antioxidant defense. |
Double-knockout mouse generation; ROS measurement; antioxidant gene expression analysis; reduced-oxygen rescue experiments |
The Journal of biological chemistry |
High |
12968018
|
| 2003 |
Nrf1 is essential specifically for the hepatocyte lineage; chimera analysis showed Nrf1-deficient cells fail to contribute to adult liver but not other tissues. Loss of Nrf1 causes hepatocyte apoptosis associated with increased oxidative stress, impaired antioxidant gene expression, and sensitization to TNF-mediated cytotoxicity. |
Chimeric mouse analysis; primary hepatocyte culture; oxidative stress assays; tert-butyl hydroperoxide and TNF challenge |
Molecular and cellular biology |
High |
12808106
|
| 2005 |
Nrf1 and Nrf2 regulate rat glutamate-cysteine ligase catalytic subunit (GCLC) transcription indirectly by modulating the expression of AP-1 (c-Jun, c-Fos) and NF-κB (p50, p65) family members, rather than directly through ARE binding, since the rat GCLC promoter lacks an ARE. |
Nrf1/Nrf2 null fibroblasts; luciferase reporter assays with mutated AP-1/NF-κB sites; Fra-1 antisense and overexpression; nuclear binding activity assays |
Molecular and cellular biology |
High |
15988009
|
| 2016 |
The aspartyl protease DDI2 (DNA-damage inducible 1 homolog 2) is required to cleave and activate Nrf1 in response to proteasome inhibition. Deletion of DDI2 reduces the cleaved form of Nrf1 and increases uncleaved cytosolic Nrf1, impairing proteasome upregulation; protease-dead DDI2 cannot rescue this defect. |
DDI2 deletion cell lines; immunoblot for Nrf1 forms; proteasome activity assays; add-back of wild-type vs. protease-defective DDI2 |
eLife |
High |
27528193
|
| 2015 |
mTORC1 signaling activates NRF1 to increase cellular proteasome levels. Loss of the TSC tumor suppressors (activating mTORC1) or physiological mTORC1 activation by growth factors/feeding stimulates NRF1-dependent transcription of proteasome subunit genes, increasing proteasome content to maintain proteostasis. |
TSC knockout cells; mTOR inhibitor (rapamycin) treatment; NRF1 knockdown; proteasome content and activity measurement |
Cell cycle (Georgetown, Tex.) |
Medium |
26017155
|
| 2018 |
Cold exposure induces Nrf1 in brown adipose tissue (BAT) to increase proteasomal activity; brown-adipocyte-specific deletion of Nrf1 results in ER stress, tissue inflammation, diminished mitochondrial function, and whitening of BAT. Exogenous Nrf1 or proteasome activator PA28α in BAT improved insulin sensitivity in obese mice. |
BAT-specific Nrf1 conditional knockout; cold-exposure model; proteasome activity assays; Nrf1 adenoviral overexpression; PA28α treatment in obese mice |
Nature medicine |
High |
29400713
|
| 2018 |
NGLY1 (N-glycanase 1) regulates mitochondrial homeostasis through NRF1; NGLY1-deficient cells show impaired mitophagy, fragmented mitochondria, and chronic innate immune activation. Pharmacological activation of NRF2 (a non-glycosylated homolog) restores mitochondrial homeostasis in NGLY1-deficient cells. |
NGLY1 knockout human and mouse cells; mitophagy assays; cGAS-STING and MDA5-MAVS pathway measurement; NRF2 pharmacological activation rescue |
The Journal of experimental medicine |
Medium |
30135079
|
| 2018 |
SIAH2 (hypoxia-activated E3 ligase) degrades NRF1 (Nuclear Respiratory Factor 1) via ubiquitination at lysine 230, reducing nuclear-encoded mitochondrial gene expression and promoting the Warburg effect and pro-tumor immune response in breast cancers. |
Ubiquitination site mutagenesis (K230); co-immunoprecipitation; in vivo tumor models; TAM polarization assays |
Nature communications |
High |
30833558
|
| 2017 |
KEAP1 binds to the Neh2-like (Neh2L) domain of NRF1 and stabilizes it, in contrast to its role in mediating NRF2 degradation. Swapping NRF1's Neh2L with NRF2's Neh2 domain renders NRF1 sensitive to KEAP1-mediated degradation; systematic mutagenesis showed that correct DLG-ETGE spacing plus specific flanking amino acids are required for KEAP1-mediated degradation. |
Isogenic KEAP1+/+ vs KEAP1-/- cell lines; domain-swap mutagenesis; site-directed mutagenesis; immunoblot for protein stability |
The Journal of biological chemistry |
High |
29255090
|
| 2000 |
NRF1 physically interacts with dynein light chain (DLC), requiring the first 26 amino acids of NRF1. NRF1 and DLC co-localize in the nucleus with a similar staining pattern. The Drosophila ortholog EWG (erect wing) also interacts with DLC and can transactivate through NRF1 binding sites, showing conservation of this interaction. |
Yeast two-hybrid screen; chemical crosslinking of purified native proteins; co-immunoprecipitation from mammalian cells; immunolocalization/confocal imaging; EWG transactivation assay on NRF1 binding sites |
Journal of cell science |
High |
11069771
|
| 2014 |
Liver-specific Nrf1 knockout mice show upregulation of xCT (cystine/glutamate antiporter) and multiple fatty acid metabolism genes, revealing that Nrf1 normally suppresses these genes under homeostatic conditions by occupying their AREs; under severe stress, Nrf1 is displaced while Nrf2 is recruited, functioning as a two-step switch. |
Inducible liver-specific Nrf1 knockout (CYP1A1-Cre); hepatic fatty acid composition analysis; glutathione measurement; gene expression analysis; ARE occupancy analysis |
Molecular and cellular biology |
High |
25092871
|
| 2018 |
O-GlcNAcylation catalyzed by OGT (O-linked N-acetylglucosamine transferase) stabilizes NRF1 and is essential for NRF1-dependent upregulation of proteasome subunit genes. OGT and HCF-1 form a complex with NRF1 (identified by immunoprecipitation/mass spectrometry). OGT inhibition sensitizes cancer cells to proteasome inhibitors in vitro and in xenograft models. |
Immunoprecipitation + mass spectrometry; OGT inhibition; xenograft mouse model; proteasome subunit gene expression |
Molecular and cellular biology |
High |
29941490
|
| 2015 |
O-GlcNAcylation by OGT negatively regulates Nrf1/TCF11, reducing both protein stability and transactivation activity. The PEST2 degron sequence within Nrf1 is the site of O-GlcNAcylation; OGT overexpression promotes Nrf1 ubiquitination and turnover. |
Co-immunoprecipitation to show Nrf1-OGT interaction; O-GlcNAcylation assay; PEST2 domain mapping; ubiquitination assay; protein stability measurement |
FEBS letters |
Medium |
26231763
|
| 2016 |
Nrf1 can be proteolytically processed and activated in a proteasome-independent manner: when all three active sites of the proteasome are completely blocked, p120 Nrf1 is still cleaved to the transcriptionally active p110 form, which enters the nucleus and activates proteasome subunit genes. |
Complete proteasome active-site inhibition; immunoblot for Nrf1 forms (p120, p110); nuclear translocation assay; PSM gene reporter |
Current biology : CB |
Medium |
27676297
|
| 2011 |
Nrf1 is ubiquitinated and regulated by the 26S proteasome: proteasome inhibition stabilizes full-length Nrf1, increases its ubiquitination, and decreases a 23 kDa N-terminal fragment, suggesting the proteasome processes Nrf1 to its active form by removing its inhibitory N-terminal ER-anchoring domain. Nrf1 has a half-life of ~5 hours. Hypoxia (1% O2) activates Nrf1 reporter activity while decreasing the repressor p65 isoform. Protein phosphatase inhibition (okadaic acid) activates, and PKC inhibition (staurosporine) represses, Nrf1 reporter activity. |
Proteasome inhibitor treatment; immunoprecipitation for ubiquitination; pulse-chase for half-life; EpRE-luciferase reporter; hypoxia treatment |
PloS one |
Medium |
22216197
|
| 2009 |
MCRS2 physically interacts with Nrf1 via its CNC-bZIP domain (residues 354–447 of Nrf1; residues 314–475 of MCRS2) and acts as a transcriptional repressor of Nrf1-mediated transactivation. MCRS2 co-localizes with Nrf1 in the nucleus without altering Nrf1 distribution. |
Yeast two-hybrid screening; GST pull-down assay; co-immunoprecipitation; immunofluorescence colocalization; luciferase reporter assays; domain mapping |
BMC cell biology |
Medium |
19187526
|
| 2019 |
PGC-1β promotes mitochondrial biogenesis and oxidative phosphorylation in myotubes via direct interaction with NRF-1 and ERRα. Deletion or mutation of NRF-1 binding sites in target gene promoters (cytochrome c, ATP synthase β, ALAS-1) attenuates PGC-1β-mediated activation. siRNA knockdown of NRF-1 ablates PGC-1β mitochondrial function. |
Promoter deletion/mutation reporter assays; siRNA knockdown of NRF-1; co-immunoprecipitation of PGC-1β with NRF-1; mitochondrial respiration measurement |
Mitochondrion |
Medium |
20561910
|
| 2021 |
PGC-1α and NRF1 transcriptionally upregulate FUNDC1 (a mitophagy receptor) by NRF1 binding to the consensus NRF1 site in the Fundc1 promoter; this coupling coordinates mitochondrial biogenesis with mitophagy. Fundc1-specific BAT knockout shows reduced mitochondrial turnover, accumulation of dysfunctional mitochondria, and impaired adaptive thermogenesis. |
ChIP for NRF1 at Fundc1 promoter; promoter reporter assay; BAT-specific Fundc1 knockout; mitochondrial function assays; thermogenesis phenotyping |
EMBO reports |
High |
33554448
|
| 2020 |
ATF4 represses NRF1 transcriptional activity by binding to the NRF1 promoter, disrupting the NRF1-TFAM axis and impairing mitochondrial biogenesis and respiratory function in alcoholic hepatitis. Hepatocyte-specific ATF4 knockout restores NRF1 and TFAM expression and attenuates alcohol-induced mitochondrial dysfunction. |
Hepatocyte-specific ATF4 KO mice; liver-specific TFAM overexpression mice; promoter binding studies; mitochondrial function assays; patient liver validation |
Gut |
High |
33177163
|
| 2019 |
NRF1 has a novel role in the brain as an integral component of non-canonical PRC1 complexes (ncPRC1.3). NRF1 is required for recruitment of ncPRC1.3 to chromatin for transcriptional activation of developmental genes; absence of AUTS2 or mutations in its HX domain impair P300 interaction and cause misregulation of NRF1-dependent developmental genes, curtailing motor neuron differentiation. |
Mouse ES cell differentiation assays; ChIP for ncPRC1.3 components; human mutation analysis; motor neuron differentiation readouts |
Molecular cell |
Medium |
34637754
|
| 2014 |
Nrf1 physically interacts with the androgen receptor (AR) and enhances AR's DNA-binding activity, functioning as a coactivator of AR transactivation. The p65-Nrf1 isoform promotes AR transactivation, while the p120-Nrf1 isoform (induced by Nrf2) suppresses it. siRNA silencing of Nrf1 attenuates AR transactivation; p65-Nrf1 overexpression enhances it. |
Co-immunoprecipitation of Nrf1 with AR; Nrf1 isoform-specific siRNA; p65-Nrf1 overexpression; AR DNA-binding assay; ARE/androgen response element reporter |
PloS one |
Medium |
24466341
|
| 2004 |
Alpha-Pal/NRF-1 binds to a specific element in the IAP/CD47 gene core promoter and transactivates it. Supershift assays confirmed NRF-1 binding; overexpression of dominant-negative NRF-1 reduces IAP promoter activity both in human cell lines and primary mouse cortical cells. |
Gel EMSA; supershift with anti-NRF-1 antibody; site-directed mutagenesis; luciferase reporter; dominant-negative NRF-1 overexpression in primary neurons |
The Journal of biological chemistry |
Medium |
14747477
|
| 2015 |
DNA methylation and NRF1 compete for occupancy at NRF1 binding sites containing CpGs. In unmethylated genomes, NRF1 occupies thousands of additional sites with increased transcription. Restoration of DNA methyltransferase activity causes remethylation at these sites and outcompetes NRF1 binding. Cooperativity with neighbouring TF motifs in cis or a partner TF in trans is required for local hypomethylation to allow NRF1 binding. |
DNase-I hypersensitivity mapping in methylation-deficient vs. restored mouse stem cells; NRF1 ChIP-seq; de novo methyltransferase add-back; cis-element mutation; trans-TF removal |
Nature |
High |
26675734
|
| 2017 |
NRF1 cooperates with DNA methylation to directly regulate germ-cell-specific genes including Asz1 during spermatogenesis. Conditional ablation of NRF1 in gonocytes dramatically downregulates germline genes, blocks germ cell proliferation, and causes male infertility in mice. |
Gonocyte-specific NRF1 conditional knockout; gene expression analysis; germline gene promoter analysis; fertility phenotyping |
FASEB journal |
Medium |
28754714
|
| 2012 |
Nrf1 promotes nucleotide excision repair (NER) by maintaining glutathione homeostasis, which enhances transcription of the NER initiation factor XPC. Nrf1 loss sensitizes keratinocytes to UVB-induced apoptosis through glutathione reduction and consequent Bik upregulation. Supplementing glutathione or XPC restores NER capacity in Nrf1-inhibited cells. |
Nrf1 knockdown in keratinocytes; UVB irradiation; NER assay; XPC promoter reporter; glutathione measurement; Bik knockdown rescue; mouse skin UVB model |
The Journal of biological chemistry |
Medium |
22500024
|
| 2015 |
Nrf1 is essential for regulating glucose-stimulated insulin secretion (GSIS) in β-cells. Nrf1 knockdown in MIN6 cells and β-cell-specific Nrf1 knockout mice show elevated basal insulin release and decreased GSIS, associated with oxidative stress and altered glucose metabolism via induction of hexokinase 1 and suppression of glucokinase. |
β-cell-specific Nrf1 knockout mice; stable Nrf1 knockdown in MIN6 cells; GSIS assay; glucose metabolic enzyme expression; oxidative stress measurement |
Antioxidants & redox signaling |
High |
25556857
|
| 2015 |
Nrf1 transcriptionally activates Herpud1 (an ER-associated degradation protein) through antioxidant response elements in the Herpud1 promoter, as shown by chromatin immunoprecipitation. Loss of Nrf1 results in decreased Herpud1 expression and abolished ER stress-induced Herpud1 upregulation. |
Nrf1 knockout cells; Herpud1 promoter ARE transactivation assay; chromatin immunoprecipitation (ChIP); ER stress induction |
FEBS letters |
Medium |
25637874
|
| 2019 |
NRF1 activates p62/SQSTM1 and GABARAPL1 transcription (aggrephagy genes) in response to proteasome dysfunction. NRF1 is required for p62-positive puncta formation, colocalization with ULK1 and TBK1, and phosphorylation of p62 at Ser403. NRF1 thus induces aggrephagy as a compensatory response when proteasomal activity is impaired. |
Genome-wide transcriptome analysis after proteasome inhibition; NRF1 knockdown; p62 puncta immunofluorescence; TBK1/ULK1 colocalization; p62 Ser403 phosphorylation assay |
Scientific reports |
Medium |
37658135
|
| 2024 |
Nrf1 transcriptionally upregulates multiple autophagy-lysosomal pathway (ALP) genes in response to proteasome inhibition. Nrf1-deficient cells display profound defects in autophagy and aggresome clearance; conversely, Nrf1 overexpression induces ALP genes and increases aggresome-clearing capacity. This phenotype is also recapitulated in NGLY1 knockout cells where Nrf1 is non-functional. |
Nrf1 KO and NGLY1 KO cell lines; autophagy flux assays; aggresome clearance assay; Nrf1 overexpression; proteasome inhibitor treatment |
The Journal of cell biology |
Medium |
38656405
|
| 2022 |
NRF1-mediated transcription requires the TIP60 chromatin-regulatory complex. RUVBL1 (an AAA+ ATPase component of TIP60) is necessary for Nrf1 transcriptional activity; Nrf1, RUVBL1, and TIP60 are co-recruited to proteasome gene promoters after proteasome inhibitor treatment. Depletion of RUVBL1 or TIP60 in cancer cells sensitizes them to proteasome-inhibitor-induced cell death. |
RNAi screen; ChIP for Nrf1/RUVBL1/TIP60 at proteasome gene promoters; TIP60/RUVBL1 depletion; cell viability assay with proteasome inhibitors |
The Journal of biological chemistry |
Medium |
30559296
|
| 2022 |
Nrf1 heterodimerizes with MafG (a small Maf protein) and the Nrf1-MafG heterodimer activates proteasome subunit genes and broader proteostasis genes (ERAD, chaperone, ubiquitin-degradation pathways) through CNC-sMaf-binding elements (CsMBEs). Transposable SINE B2 repeats harbor CsMBEs and contribute to target gene diversity. |
Tethered Nrf1-MafG heterodimer in small Maf triple-KO fibroblasts; ChIP-seq; RNA-seq; CsMBE motif analysis |
Molecular and cellular biology |
Medium |
35129372
|
| 2019 |
Distinct Nrf1 isoforms (Nrf1α, Nrf1β, Nrf1γ) regulate different subsets of target genes. Nrf1α and Nrf1β are the dominant activators of ARE-driven genes (>90% of DEGs). Nrf1γ regulates far fewer genes and acts primarily as a dominant-negative inhibitor counteracting Nrf1α/β activity on proteasomal subunit genes and other targets. |
Tetracycline-inducible stable expression of each isoform in Flp-In T-REx cells; RNA-sequencing; quantitative RT-PCR validation |
Scientific reports |
Medium |
30814566
|
| 2019 |
Long isoforms of NRF1 (L-NRF1, 741/742 aa) negatively regulate adipogenesis by suppressing transcription of PPARγ2, the master regulator of adipogenesis. Short NRF1 isoforms lack this function; overexpression of L-NRF1-741 attenuates adipogenic differentiation in 3T3-L1 cells. |
Adipocyte-specific Nrf1 KO mice; lentiviral shRNA KD of long/short isoforms; L-NRF1-741 overexpression; PPARγ2 promoter reporter; adipogenic differentiation assays |
Redox biology |
Medium |
31931283
|
| 2023 |
Virus-activated kinase TBK1 phosphorylates NRF1 at Ser318, triggering inactivation of the NRF1-TFAM axis during HSV-1 infection, thereby promoting mitochondrial damage, mtDNA release, and innate immune activation. A Ser318 knock-in model that mimics TBK1 phosphorylation ablates mtDNA release and attenuates the innate response. |
TBK1-NRF1 interaction studies; phosphorylation site mapping (Ser318); knock-in mouse model; mtDNA release assay; innate immune activation measurement |
The EMBO journal |
High |
37409632
|
| 2024 |
SCFFBS2 (an N-glycan-recognizing E3 ligase) cooperates with the RBR-type E3 ligase ARIH1 and E2 enzyme UBE2L3 to ubiquitinate Nrf1 through oxyester bonds on N-GlcNAc residues generated by ENGASE. These atypical ubiquitin chains on Nrf1 inhibit DDI2-mediated cleavage and Nrf1 activation. This pathway was reconstituted on glycopeptides in vitro. |
In vitro reconstitution of polyubiquitination on N-GlcNAc and serine/threonine residues; SCFFBS2-ARIH1-UBE2L3 biochemical assay; Nrf1 activation assay in human cells |
Molecular cell |
High |
39116872
|
| 2019 |
NRF1 binding to the NRF1 consensus site in the Fundc1 promoter directly regulates StAR (steroidogenic acute regulatory protein) transcription; NRF1 binds two sites on the Star promoter at -1445/-1422 and -44/-19. Knockdown of NRF1 synchronously reduces StAR expression and testosterone production; regulation confirmed by ChIP, EMSA supershift, and mutation assays. |
Dual-luciferase reporter assay; ChIP; EMSA with supershift; mutation of NRF1-binding sites; NRF1 overexpression/knockdown in hypoxia model |
The Journal of steroid biochemistry and molecular biology |
Medium |
31028793
|
| 2019 |
CDK2 binds to the Ehmt1 promoter via interaction with NRF1 and phosphorylates NRF1 at two distinct serine residues, negatively regulating NRF1 DNA-binding activity in vitro. Induced deletion of Cdk2 in spermatocytes results in increased expression of many NRF1 target genes including Ehmt1, modulating H3K9 methylation during meiotic prophase I. |
ChIP for CDK2/NRF1 at Ehmt1 promoter; in vitro kinase/phosphorylation assay; CDK2 conditional KO in spermatocytes; NRF1 target gene expression; H3K9 methylation analysis |
The Journal of cell biology |
Medium |
31350280
|
| 2018 |
LSD1-ERRα transcriptional activation complex requires promoter-bound NRF1 for recruitment to transcription start sites. NRF1 acts as a TSS tethering factor but does not affect LSD1 enzymatic activity; all three factors (NRF1, LSD1, ERRα) are required for H3K9me2 demethylation and cell invasion in an MMP1-dependent manner. |
ChIP for LSD1/ERRα/NRF1 at target gene TSSs; NRF1 depletion; H3K9 methylation assay; MMP1 expression; cell invasion assay |
Scientific reports |
Medium |
29968728
|
| 2021 |
Nrf1 is activated in regenerating neonatal cardiomyocytes and its genetic deletion prevents activation of the transcriptional program required for heart regeneration. Nrf1 overexpression protects adult mouse hearts from ischemia/reperfusion injury and human iPSC-derived cardiomyocytes from doxorubicin toxicity. Protective function involves dual activation of the proteasome and redox balance. |
Neonatal heart regeneration model; cardiac Nrf1 genetic deletion; Nrf1 overexpression in adult I/R model; iPSC-cardiomyocyte toxicity assay; proteasome and redox activity measurement |
Nature communications |
High |
34489413
|
| 2022 |
ARMC5 regulates NRF1 protein turnover via ubiquitination; ARMC5 inactivation in adrenocortical cells increases NRF1 half-life and expression of NRF1 target antioxidant genes (SODs, peroxiredoxins), altering steroidogenesis through p38 pathway activation. |
ARMC5 inactivation in adrenocortical cells; NRF1 ubiquitination assay; NRF1 half-life measurement; antioxidant gene expression; steroidogenesis assay |
Endocrine-related cancer |
Medium |
36040830
|
| 2024 |
HDAC3 deacetylates NRF1; PTS (pterostilbene) decreases HDAC3 activity, increasing NRF1 acetylation at lysines K105 and K139 in the nucleus. Acetylated NRF1 inhibits its interaction with p65 (NF-κB), reducing neuroinflammation after ischemic stroke. K105R/K139R Nrf1 mutants counteract PTS-mediated protection in the OGD/R microglial injury model. |
Dual-luciferase reporter assay; co-immunoprecipitation of Nrf1 with p65; Nrf1 acetylation assay; K105R/K139R mutagenesis; MCAO/R mouse model; OGD/R microglial model |
Cellular & molecular biology letters |
Medium |
39198723
|
| 2024 |
In macrophages exposed to LPS, NRF1 drives increased flux through the ubiquitin proteasome system to degrade ubiquitinated mitochondrial proteins. Absence of NRF1 causes accumulation of ubiquitinated mitochondrial proteins, severe mitochondrial stress, engagement of the ISR-ATF4 axis, and amplified inflammatory responses increasing susceptibility to septic shock. |
NRF1 KO macrophages; LPS stimulation; proteasome flux measurement; ubiquitinated mitochondrial protein accumulation; ATF4 pathway analysis; septic shock model |
Cell reports |
Medium |
39325625
|
| 2011 |
NRF1 transactivates the promoters of PRDX3 and PRDX5 (but not PRDX2 or PRDX4) in trabecular meshwork cells; NRF1 knockdown reduces PRDX3 and PRDX5 expression and sensitizes cells to H2O2. Quercetin-induced NRF1 activation requires upstream Nrf2, establishing an Nrf2/NRF1 pathway axis. |
siRNA knockdown of NRF1; luciferase reporter assay with PRDX3/5 promoters; Western blot; oxidative stress sensitivity assay; Nrf2 knockdown blocking Nrf1 activation |
Investigative ophthalmology & visual science |
Medium |
21051700
|
| 2013 |
In Drosophila indirect flight muscles, the transcription factor Erect wing (EWG, the Drosophila ortholog of NRF1) directly regulates the mitochondrial inner membrane fusion gene Opa1-like in a spatiotemporal fashion. In Ewg-null muscles, mitochondria undergo mitophagy/autophagy with reduced mitochondrial function and muscle degeneration. EWG expression during early IFM development is sufficient to upregulate Opa1-like for late pupal mitochondrial fusion and muscle maintenance. |
Drosophila Ewg null mutant IFMs; Opa1-like knockdown in specific developmental windows; mitochondrial morphology imaging; muscle degeneration assay |
Journal of cell science |
Medium |
24198395
|
| 2023 |
NRF1 directly binds the METTL3 promoter to upregulate METTL3 expression, promoting m6A methylation and IGF2BP2-dependent stability of GLRX (glutaredoxin) mRNA. This NRF1/METTL3/GLRX axis protects against motor dysfunction and dopaminergic neuron degeneration in MPTP-induced Parkinson's disease mice; METTL3 knockdown counteracts NRF1 overexpression benefits. |
ChIP assay for NRF1 at METTL3 promoter; dual luciferase reporter; RIP (RNA immunoprecipitation); MeRIP for m6A levels; NRF1 OE + METTL3 KD rescue in MPTP mice |
CNS neuroscience & therapeutics |
Medium |
37735974
|